Curriculum Vitae. Sun-Young Kim, PhD

Transcription

1 Curriculum Vitae Sun-Young Kim, PhD 7411 John Smith Drive, Suite 1100, San Antonio, Texas 78229, United States Tel: , Fax: , Education: Harvard University Graduate School of Arts and Sciences, Cambridge, MA PhD (Health Policy; Decision Science concentration) 2006 Seoul National University School of Public Health, Seoul, Korea MPH (Health Policy and Management; Health Economics track), valedictorian 2000 Seoul National University College of Pharmacy, Seoul, Korea BS (Pharmacology), cum laude 1995 Major Work Experience: University of Texas School of Public Health, San Antonio Regional Campus, San Antonio, TX Department of Management, Policy and Community Health Assistant Professor 2012-present Consultant (Lead investigator) on a CDC-sponsored vaccine economics project Department of Health Policy and Management Research Scientist (Core faculty member) Harvard University, Cambridge, MA Harvard Initiative for Global Health Senior Research Fellow Schering (Korea) Ltd., Seoul, Korea Clinical Research Associate Fellowships, Awards and Honors: Harvard University Pascucci Graduate Student Dissertation Fellowship 2006 Harvard University, Graduate School of Arts and Sciences Graduate Society Dissertation Completion Fellowship 2006 Novartis AG Novartis Training Fellowship 2005 Harvard University Harvard Ph.D. in Health Policy Program Fellowship Student Prize for the Highest Academic Achievement Seoul National University (SNU), School of Public Health 2000 SNU Development Foundation Scholarship for Highest Academic Excellence Seoul National University 1999 Appreciation Award for Exemplary Work Schering (Korea) Ltd SNU Tuition Scholarship for Academic Achievement Seoul National University, College of Pharmacy

2 Professional Services: Editorial Boards: - Medical Decision Making, & Annals of Vaccines and Immunization, Supplementary issue to the journal Vaccine titled: Expanding the evidence base to inform vaccine introduction: program costing and cost-effectiveness analyses, Supplementary issue to the journal Vaccine titled: Evidence-based vaccine introduction in Latin America and the Caribbean, 2012 Expert Panels: - Panelist on the PAHO Expert Panel to review ProVac practical guides on disease burden, health services utilization, and healthcare costs, Panelist on the PAHO ProVac Expert Panel on the cost-effectiveness of pneumococcal/rotavirus vaccines in Latin America and the Caribbean, 2009 Conference: - Planning Committee (Scientific Co-Chair) for Inaugural SMDM-Asia Meeting, Singapore, 2014 Ad Hoc Reviewer: 1) Grant Proposal Review - Health and Medical Research Fund, Research Office, Food and Health Bureau, the Hong Kong SAR Government - Innovational Research Incentives Scheme (Veni)-2012 Rounds, Netherlands Organization for Scientific Research - ReACH Pilot Grant Program 2012, ReACH Center, San Antonio, TX 2) Final Grant Report Review - Health and Medical Research Fund, Research Office, Food and Health Bureau, the Hong Kong SAR Government 3) Journal Review - PLOS ONE - Bulletin of the World Health Organization - American Journal of Public Health - Preventive Medicine - Annals of Internal Medicine - Epidemiology and Infection - Health Economics Review - Pharmacoeconomics - Vaccine - PLOS Neglected Diseases - Expert Review of Vaccines - BMC Health Services Research - Global Public Health - Southeast Asian Journal of Tropical Medicine and Public Health - Israel Journal of Health Policy Research - International Journal for Vitamin and Nutrition Research - Future drugs 4) Conference Abstract Review - Scientific Review Committee, SMDM Annual Meeting Scientific Review Committee, SMDM-Asia Meeting Scientific Review Committee, APHA Annual Meeting

3 - Scientific Committee, 9 th World Congress on Health Economics Scientific Committee, European Conference on Health Economics 2012 Professional Memberships: Society for Medical Decision Making International Health Economics Association American Public Health Association South-South Initiative for Infectious Diseases of Poverty Major Research Experience: 1) Funding Organization: The Bill and Melinda Gates Foundation Project Title: Maternal immunization to prevent neonatal deaths due to sepsis and meningitis in GAVI-eligible, sub-saharan African countries: Cost-effectiveness of group B streptococcal vaccine Inclusive Dates of Funding: 4/2014-3/2016 2) Funding Organization: CDC Project Title: Decision-analytic modeling of the cost-effectiveness of group B streptococcal maternal immunization Inclusive Dates of Funding: 9/2013-9/2015 3) Funding Organization: CDC (Year 1) and PATH (Year 2) Project Title: Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa Inclusive Dates of Funding: 9/2010-8/2013 4) Funding Organization: The Bill and Melinda Gates Foundation Project Title: Development and Evaluation of HPV Vaccines and Related Diagnostics: Global Policy Model (#30505) Inclusive Dates of Funding: ) Funding Organization: Pan American Health Organization (PAHO) Project Title: ProVac Initiative, HPV Vaccine Costing Study Inclusive Dates of Funding: ) Funding Organization: The Bill and Melinda Gates Foundation Project Title: Grand Challenge #13: Population Health Metrics Research Consortium Project Inclusive Dates of Funding: 7/2005-6/2008 7) Funding Organization: National Immunization Program, CDC Project Title: Joint Initiative in Vaccine Economics (JIVE), Hepatitis B vaccination of patients at risk for HIV (TS-0675) Inclusive Dates of Funding:

4 Teaching and Training Experience: Courses: University of Texas School of Public Health, Houston, TX Decision Analysis in Public Health Summer 2014, Spring 2015 Instructor University of Texas School of Public Health, Houston, TX Introduction to Comparative Effectiveness Research Fall 2013, Fall 2014 Course Director University of Texas School of Public Health, Houston, TX Advanced Health Services Research Methods Spring 2013, Fall 2014 Co-Instructor Practice of Health Care Management & Policy Spring 2009 Preceptor Decision Science Advanced Methods Seminar and Academic Years Co-Instructor Seminar for doctoral students in decision science Fall 2006-Winter 2007 Coordinator/Session Instructor Other Training: Pan American Health Organization, Bridgetown, Barbados 2009 Technical Meeting on the Immunization Costing Methods Delivered a talk on immunization costing and financing and trained the Barbados National Immunization Program Team on the use of an Excel-based immunization costing tool. Pan American Health Organization, Kingston, Jamaica 2009 ProVac Workshop on the HPV Costing Contributed to developing training materials for the HPV Costing Workshop which aimed to train the Expanded Program on Immunization managers from the Caribbean region, and served as a moderator during the workshop. Pan American Health Organization, Asuncion, Paraguay 2008 ProVac Workshop on the Cost-effectiveness of Pneumococcal Conjugate Vaccines As a moderator, facilitated discussion among a group of participants from the Caribbean region during the workshop. WHO-Seoul National University-Hanoi Medical School, Haiphong, Vietnam 2007 Training Course on Health Economics and Financing As a session instructor, gave several lectures for Vietnamese government health/finance officials on various topics in health economics and international health, including the basics of microeconomics, priority setting and resource allocation, burden of disease analysis, macroeconomics and health, international trade and health, and supply of pharmaceuticals. 4

5 Publications (Peer-reviewed): Kim SY, Sagiraju HKR, Russell L, Sinha A. Willingness-to-pay for vaccines in low- and middle-income countries: A systematic review. Ann Vaccines Immunization 2014;1(1):1001. Kim SY, Russell L, Park J, Verani J, Madhi S, Cutland C, Schrag S, Sinha A. Costeffectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine 2014;32(17): Kim SY, Choi Y, Mason PR, Rusakaniko S, Goldie SJ. Potential Impact of Reactive Vaccination in Controlling Cholera Outbreaks: An Exploratory Analysis Using a Zimbabwean Experience. SAMJ 2011;101(9): Kim SY, Sweet S, Chang J, Goldie SJ. Comparative Evaluation of the Potential of Rotavirus versus HPV Vaccination in GAVI-Eligible Countries: A Preliminary Analysis Focused on the Relative Disease Burden. BMC Infectious Diseases 2011;11:174. Kim SY, Lee G, Goldie SJ. Economic Evaluation of Pneumococcal Conjugate Vaccination in The Gambia. BMC Infectious Diseases 2010;10:260. Kim SY, Goldie SJ, Salomon JA. Exploring Model Uncertainty in Economic Evaluation of Health Interventions: the Example of Rotavirus Vaccination in Vietnam. Medical Decision Making 2010;30:E1-28. Kim SY, Sweet S, Slichter D, Goldie SJ. Health and Economic Impact of Rotavirus Vaccines in GAVI-eligible Countries. BMC Public Health 2010;10:253. Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of Rotavirus Vaccination in Vietnam. BMC Public Health 2009;1:29. Park S, Kim SY, Earle CC, Jeong S, Yun Y. What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea? World J Gastroenterol 2009;15(25): Goldie SJ, O Shea M, Diaz M, Kim SY. Preventable Deaths of Women in Developing Countries: The Case for Prioritizing Public Health Investments in Cervical Cancer Prevention. Reproductive Health matters 2008;16(32): Goldie SJ, Diaz M, Constenla D, Alvis N, Andrus J, Kim SY. Regional Report on HPV Vaccines and Screening Latin America. Chapter 13: Mathematical models of cervical cancer prevention in Latin America and the Caribbean. Vaccine 2008;26S:L59-L72. Goldie SJ, Diaz M, Kim SY, Levin C, Minh HV, Kim JJ. Mathematical models of cervical cancer prevention: Chapter 19, Regional Report on HPV Vaccines and Screening Asia and the Pacific. Vaccine 2008;26S:M17 M29. Goldie SJ, O Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 Vaccination in 72 GAVI-eligible countries. Vaccine 2008;26(32): Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics 2008;26(3): Kim SY, Salomon JA, Goldie SJ. Economic Evaluation of Hepatitis B vaccination in Low Income Countries: An Application of Cost-effectiveness Affordability Curves. Bulletin of the World Health Organization 2007;85(11): Kim SY, Billah K, Lieu TA, Weinstein MC. Cost-effectiveness of Hepatitis B Vaccination at HIV Counseling and Testing Sites. AJPM 2006;36: Kim SY, Yang B. Cost-effectiveness Analysis of Alternative Medications in Treating Hypertension in Korea. Korean Health Economics Review 2000;6(1): Han E, Kang S, Kim SY, Yang B. Review of Medical Savings Account as a Method for Health Care Financing. Korean Health Economics Review 1999;5: Publications (Non-peer reviewed): 5

6 Kim SY. Use of a decision-analytic model in a health technology assessment: beyond measure of money for value. Israel Journal of Health Policy Research 2013;2:15. Conference Presentations/Abstracts: Kim SY, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A. Health Impact of Maternal Group B Streptococcal Vaccination on Neonatal Sepsis and Meningitis in South Africa. Rutgers Foundation Annual Global Health Fair, New Brunswick, NJ, 2013 Kim SY, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A. Expanding the Range of Comparators for Cost-Effectiveness Analyses of Vaccines: The example of a potential group B streptococcal (GBS) vaccine program for pregnant women in South Africa. Society for Medical Decision Making Annual Meeting, Baltimore, MD, 2013 Kim SY, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A. The Value of Reducing Uncertainties about Vaccination Programs in Low- and Middle-Income Countries. Society for Medical Decision Making Annual Meeting, Baltimore, MD, 2013 Goldie SJ, Sweet S, O Shea M, Levin C, Kim SY. HPV 16,18 vaccination of girls in GAVIeligible countries: What is the consequence of a delay? The 26th International Papillomavirus Conference, Montreal, Canada, 2010 Kim SY, Goldie SJ, Salomon JA. Exploring Model Uncertainty in Economic Evaluation of Rotavirus Vaccination. Society for Medical Decision Making Annual Meeting, Hollywood, CA, 2009 Kim SY, Lee G, Goldie SJ. The Impact of Different Classification of Pneumonia on the Costeffectiveness of a Pneumococcal Conjugate Vaccine in The Gambia. Society for Medical Decision Making Annual Meeting, Hollywood, CA, 2009 Goldie SJ, O Shea M, Diaz M, Sweet SG, Andrus J, Kim SY. Economic Evaluation of HPV vaccines in 72 GAVI countries. The 7th World Congress of International Health Economics Association, Beijing, China, 2009 Goldie SJ, O Shea M, Campos NG, Diaz M, Sweet SG, Kim SY. Health and Economic Impact of HPV 16 and 18 Vaccination in GAVI-eligible countries. Society for Medical Decision Making Annual Meeting, Philadelphia, PA, 2008 Goldie SJ, Sweet SG, Diaz M, Constenla D, Nelson A, Andrus J, Sweet SG, Kim SY. Health and Economic Impact of HPV 16 and 18 Vaccination in Latin America and the Caribbean. Society for Medical Decision Making Annual Meeting, Philadelphia, PA, 2008 Kim SY, Salomon JA, Goldie SJ, Weinstein MC. Quantifying Externalities due to Hepatitis B Vaccination in the United States. Society for Medical Decision Making Annual Meeting, Boston, MA, 2006 Kim SY, Salomon JA, Goldie SJ. Economic Evaluation of Universal Infant Hepatitis B vaccination in the Gambia with Consideration of Affordability. The 5th World Congress of International Health Economics Association, Barcelona, Spain, 2005 Kim SY, Goldie SJ. Economic Evaluation of Hepatitis B Vaccination: High-endemic Developing Country versus Low-endemic Developed Country. Society for Medical Decision Making Annual Meeting, Chicago, IL,